$AWRE
AWARE INC /MA/

2023 Q2 Form 10-Q Financial Statement

#000095017023017158 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $3.184M $4.305M $4.692M
YoY Change -24.87% -8.25% 6.18%
Cost Of Revenue $325.0K $298.0K $314.0K
YoY Change 0.31% -5.1% -18.02%
Gross Profit $2.859M $4.007M $4.378M
YoY Change -26.95% -8.47% 8.47%
Gross Profit Margin 89.79% 93.08% 93.31%
Selling, General & Admin $3.530M $3.495M $3.242M
YoY Change 16.19% 7.8% 4.95%
% of Gross Profit 123.47% 87.22% 74.05%
Research & Development $2.265M $2.381M $2.424M
YoY Change 1.62% -1.77% 1.17%
% of Gross Profit 79.22% 59.42% 55.37%
Depreciation & Amortization $149.0K $149.0K $225.0K
YoY Change -32.58% -33.78% 27.12%
% of Gross Profit 5.21% 3.72% 5.14%
Operating Expenses $5.795M $5.876M $5.666M
YoY Change 10.02% 3.71% 3.3%
Operating Profit -$2.936M -$1.869M -$1.288M
YoY Change 117.0% 45.11% -11.11%
Interest Expense $284.0K $301.0K $9.000K
YoY Change 343.75% 3244.44%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.652M -$1.568M -$1.279M
YoY Change 105.74% 22.6% -11.67%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.652M -$1.568M -$1.278M
YoY Change 105.74% 22.69% -11.74%
Net Earnings / Revenue -83.29% -36.42% -27.24%
Basic Earnings Per Share -$0.13 -$0.07 -$0.06
Diluted Earnings Per Share -$0.13 -$0.07 -$59.10K
COMMON SHARES
Basic Shares Outstanding 20.96M 20.99M 21.64M
Diluted Shares Outstanding 20.97M 21.03M 21.64M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.06M $27.31M $25.08M
YoY Change 0.31% 8.89% -30.33%
Cash & Equivalents $3.313M $8.400M $25.10M
Short-Term Investments $21.75M $18.91M
Other Short-Term Assets $718.0K $839.0K $985.0K
YoY Change -81.33% -14.82% 97.0%
Inventory
Prepaid Expenses
Receivables $6.837M $2.670M $7.306M
Other Receivables $1.498M $1.362M $1.411M
Total Short-Term Assets $34.11M $35.66M $34.78M
YoY Change -9.91% 2.51% -17.03%
LONG-TERM ASSETS
Property, Plant & Equipment $5.054M $697.0K $3.095M
YoY Change 4372.57% -77.48% -13.23%
Goodwill $3.120M $3.120M
YoY Change 0.0%
Intangibles $2.599M $2.703M
YoY Change -13.77%
Long-Term Investments
YoY Change
Other Assets $122.0K $122.0K
YoY Change
Total Long-Term Assets $13.56M $13.74M $11.84M
YoY Change 54.33% 16.08% 51.99%
TOTAL ASSETS
Total Short-Term Assets $34.11M $35.66M $34.78M
Total Long-Term Assets $13.56M $13.74M $11.84M
Total Assets $47.67M $49.40M $46.62M
YoY Change 2.19% 5.95% -6.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $595.0K $624.0K $472.0K
YoY Change 7.01% 32.2% -6.35%
Accrued Expenses $1.516M $780.0K $1.260M
YoY Change -15.26% -38.1% -3.3%
Deferred Revenue $3.704M $3.204M
YoY Change 19.6%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.627M $6.043M $5.209M
YoY Change 13.32% 16.01% -0.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.603M $4.590M $742.0K
YoY Change 385.04% 518.6% 642.0%
Total Long-Term Liabilities $4.603M $4.590M $742.0K
YoY Change 385.04% 518.6% 642.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.627M $6.043M $5.209M
Total Long-Term Liabilities $4.603M $4.590M $742.0K
Total Liabilities $11.23M $10.63M $5.951M
YoY Change 65.22% 78.68% 10.2%
SHAREHOLDERS EQUITY
Retained Earnings -$62.42M -$59.77M
YoY Change 5.72%
Common Stock $98.95M $98.50M
YoY Change 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.44M $38.77M $40.67M
YoY Change
Total Liabilities & Shareholders Equity $47.67M $49.40M $46.62M
YoY Change 2.19% 5.95% -6.22%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.652M -$1.568M -$1.278M
YoY Change 105.74% 22.69% -11.74%
Depreciation, Depletion And Amortization $149.0K $149.0K $225.0K
YoY Change -32.58% -33.78% 27.12%
Cash From Operating Activities -$2.214M -$1.485M -$2.381M
YoY Change 1150.85% -37.63% -3.64%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $16.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$2.915M -$1.502M -$2.500M
YoY Change -39.92%
Cash From Investing Activities -$2.915M -$1.518M -$2.500M
YoY Change 26400.0% -39.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.00K -356.0K 0.000
YoY Change -42.22% -100.0%
NET CHANGE
Cash From Operating Activities -2.214M -1.485M -2.381M
Cash From Investing Activities -2.915M -1.518M -2.500M
Cash From Financing Activities 52.00K -356.0K 0.000
Net Change In Cash -5.077M -3.359M -2.500M
YoY Change 5080.61% 34.36% -0.99%
FREE CASH FLOW
Cash From Operating Activities -$2.214M -$1.485M -$2.381M
Capital Expenditures $0.00 $16.00K
Free Cash Flow -$2.214M -$1.501M
YoY Change 1233.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001015739
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity File Number
EntityFileNumber
000-21129
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AWARE, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2911026
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
76 Blanchard Road in Burlington
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Burlington
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01803
CY2023Q1 dei City Area Code
CityAreaCode
781
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
276-4000
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20955339
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8390000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11749000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
18912000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
17229000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2670000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3317000
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3483000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2929000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1362000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
AWRE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1362000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49400000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
839000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21093447
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21093447
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
693000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
35656000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
37279000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
697000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
726000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2703000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2806000
CY2023Q1 us-gaap Goodwill
Goodwill
3120000
CY2022Q4 us-gaap Goodwill
Goodwill
3120000
CY2023Q1 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
2632000
CY2022Q4 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
2601000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4470000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4538000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
122000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
122000
CY2023Q1 us-gaap Assets
Assets
49400000
CY2022Q4 us-gaap Assets
Assets
51192000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
624000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
639000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1282000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
623000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
470000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3204000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3411000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
812000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6043000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5802000
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
592000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
322000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3998000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4047000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
812000
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4590000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5181000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20955339
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20955339
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
210000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
211000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
98286000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
98306000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59766000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58198000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
37000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
63000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-440000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
38767000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
40209000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1485000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2381000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51192000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4305000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4692000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
298000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
314000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2381000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2424000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1991000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1781000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1504000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1461000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
6174000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
5980000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1869000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1288000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
301000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1568000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1279000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21033000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21642000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21033000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21642000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
147000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1421000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1279000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1568000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1279000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
225000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
335000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
430000
CY2023Q1 awre Accrued Interest Receivable
AccruedInterestReceivable
31000
CY2022Q1 awre Accrued Interest Receivable
AccruedInterestReceivable
7000
CY2023Q1 awre Non Cash Lease Expense
NonCashLeaseExpense
173000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-417000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
368000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
325000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
88000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
181000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
394000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2752000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1250000
CY2022Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2500000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1518000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
190000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-502000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-650000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2500000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
341000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-356000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3359000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4881000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11749000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29963000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8390000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25082000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41522000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
430000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1279000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
40673000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
40209000
CY2023Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
15000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
341000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
335000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
147000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1568000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
38767000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:20.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.4%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for credit losses, valuation of the contingent acquisition payment, valuation of the investment in the note receivable, goodwill and long-lived asset impairment and valuation allowance for deferred income tax assets. Actual results could differ from those estimates.</span></p>
CY2022Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1221000
CY2022Q1 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1661000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3300000
CY2023Q1 awre Percentage Of Remaining Performance Obligations Expected To Be Recognized As Revenue
PercentageOfRemainingPerformanceObligationsExpectedToBeRecognizedAsRevenue
0.67
CY2023Q1 awre Minimum Period Of Remaining Performance Obligations
MinimumPeriodOfRemainingPerformanceObligations
P12M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1900000
CY2023Q1 awre Minimum Period Of Payment Of Transaction Price In Contract With Customer
MinimumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P30D
CY2023Q1 awre Maximum Period Of Payment Of Transaction Price In Contract With Customer
MaximumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P60D
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4305000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4692000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2929000
CY2023Q1 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
2340000
CY2023Q1 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
1786000
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3483000
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3087000
CY2022Q1 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
1486000
CY2022Q1 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
1398000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8400000
CY2022Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3175000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3733000
CY2023Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1898000
CY2023Q1 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1835000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3796000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3740000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11700000
CY2023Q1 awre Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
858000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2703000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18875000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
87000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
50000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18912000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
17339000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
24000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
17229000
CY2022Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
2601000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3420000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
717000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2703000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
311000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
415000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
407000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
356000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
356000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
335000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
430000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 awre Estimated Benefit Amount Federal Tax Refund Receivable
EstimatedBenefitAmountFederalTaxRefundReceivable
1400000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
awre-20230331_cal.xml Edgar Link unprocessable
awre-20230331_lab.xml Edgar Link unprocessable
0000950170-23-017158-index-headers.html Edgar Link pending
0000950170-23-017158-index.html Edgar Link pending
0000950170-23-017158.txt Edgar Link pending
0000950170-23-017158-xbrl.zip Edgar Link pending
awre-20230331.htm Edgar Link pending
awre-20230331.xsd Edgar Link pending
awre-ex31_1.htm Edgar Link pending
awre-ex31_2.htm Edgar Link pending
awre-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
awre-20230331_def.xml Edgar Link unprocessable
awre-20230331_htm.xml Edgar Link completed
awre-20230331_pre.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending